greeksoup/ stock research
Stock research / United States / KRYS / Planned sales

Krystal Biotech, Inc. planned insider sales

In the twelve months since 9 October 2025 insiders at Krystal Biotech, Inc. filed 19 Form 144 notices of planned sales, 330,806 shares worth $94.6 million at the time of filing, from 8 sellers. The latest, filed 4 September 2026: Suma Krishnan (director, officer, 10% stockholder), 25,000 shares worth $9.3 million, planned for around 4 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
4 September 2026Suma KrishnanDirector, Officer, 10% Stockholder25,000$9.3 million4 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
4 September 2026Krish KrishnanDirector, Officer, 10% Stockholder25,000$9.3 million4 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
14 August 2026Dino A. RossiDirector25,000$8.3 million14 August 2026Goldman Sachs & Co. LLCAcquired from public marketForm 144
25 June 2026Thomas John CharlesOfficer1,000$347,27025 June 2026Fidelity Brokerage Services LLCStock Option ExerciseForm 144
4 June 2026Suma KrishnanDirector, Officer, 10% Stockholder25,000$7.5 million4 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
4 June 2026Krish KrishnanDirector, Officer, 10% Stockholder25,000$7.5 million4 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
26 May 2026Thomas John CharlesOfficer642$193,90326 May 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
4 March 2026Suma KrishnanDirector, Officer, 10% Stockholder25,000$6.6 million4 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
4 March 2026Krish KrishnanDirector, Officer, 10% Stockholder25,000$6.6 million4 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
2 March 2026Romano KathrynOfficer750$200,7002 March 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
27 February 2026Daniel S JanneyDirector11,803$3.3 million27 February 2026Merrill LynchPrivate PlacementForm 144
26 February 2026Daniel S JanneyDirector7,741$2.1 million26 February 2026Merrill LynchPrivate PlacementForm 144
25 February 2026Daniel S JanneyDirector700$192,50025 February 2026Merrill LynchPrivate PlacementForm 144
24 February 2026Daniel S JanneyDirector13,825$3.7 million24 February 2026Merrill LynchPrivate PlacementForm 144
24 February 2026Janney DanielDirector37,895$10.1 million24 February 2026Fidelity Brokerage Services LLCOption Granted 11/10/2016Form 144
19 February 2026Rossi Dino ADirector18,950$5.0 million19 February 2026Fidelity Brokerage Services LLCOption Granted - 06/01/2017Form 144
9 February 2026Romano KathrynOfficer12,500$3.5 million9 February 2026Fidelity Brokerage Services LLCOption Granted - 02/28/2022Form 144
4 December 2025Krish KrishnanDirector, Officer, 10% Stockholder25,000$5.4 million4 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
4 December 2025Suma KrishnanDirector, Officer, 10% Stockholder25,000$5.4 million4 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesFounders SharesForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Krystal Biotech, Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install